Publications
-
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression
Journal of Alzheimer’s Disease; 2012 Jul 5. DOI: 10.3233/JAD-2012-120625
Maetzler W, Langkamp M, Lerche S et al (2011) -
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis
FEBS Letters (2012), doi:10.1016/j.febslet.2012.06.040
Tavassoly, O., Lee, J.S. (2011) -
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
Prabhudesai, S., Sinha, S., Attar, A., et al (2011) -
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714
Vasudevaraju, P., Guerrero, E., Hegde, ML, et al (2011) -
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.
Kovacs, GG, Wagner, U., Dumont, B. et al (2011) -
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
Martin, Z. S., Neugebauer, V., Dineley, K. T., et al (2011) -
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI:10.1016/j.neulet.2011.12.001.
Tousi, A.S., Buck, D.J., Curtis, T., et al (2011) -
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A 38, A 40, and A 42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls
Journal of Alzheimer’s Disease; DOI: 10.3233/JAD-2012-121471.
Pannee J, Portelius E, Oppermann M et al (2011) -
Methods for Measuring Tau Pathology in Transgenic Mouse Models
Journal of Alzheimer’s Disease; DOI 10.3233/JAD-2012-121354
Forest SK, Acker CM, d'Abramo C, Davies P. (2011) -
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Journal of Neurochemistry; https://doi.org/10.1111/j.1471-4159.2012.07911.x.
Luk C, Compta Y, Magdalinou N, et al (2011) -
Constitutive secretion of tau protein by an unconventional mechanism
Neurobiol Dis 2012 Dec;48(3):356-66. doi: 10.1016/j.nbd.2012.05.021. Epub 2012 Jun 2
Chai, X., Dage, J.L., Citron, M. (2011) -
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Neurobiol Aging. 2013 Jan;34(1):338-50. doi: 10.1016/j.neurobiolaging.2012.05.010
Acker, C.M., Forest, S.K., Zinkowski, R., et al (2011) -
Nanopore Analysis: An emerging technique for studying the folding and misfolding of proteins
Prion; 2012 Apr 1;6(2):116-23. Epub 2012 Apr 1.pp 116-123 DOI /10.4161/pri.18665
Madampage, C., Tavassoly, O., Christensen, C., Kumari, M., Lee, J.S. (2011) -
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Cell 2012 Mar 30;149(1):232-44. doi: 10.1016/j.cell.2012.02.016
Nakamura, K., Greenwood, A., Binder, L., et al (2011) -
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
The Journal of Biological Chemistry 287, 3842-3849. doi: 10.1074/jbc.M111.277061
Saman, S., Kim, W, Raya, M. et al (2011) -
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies
J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.
Wilhelmus, M. M., de Jager, M., Rozemuller, A. J. et al (2011) -
The acute inflammatory response to intranigral a-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
J Neuroinflammation. 2011 Nov 28:8:166. doi: 10.1186/1742-2094-8-166.
Couch, Y, Alvarez-Erviti, L., Sibson, NR et al (2010) -
The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
Biochim Biophys Acta. 2011 Oct;1808(10):2343-51. doi: 10.1016/j.bbamem.2011.06.017
Fantini, J., Carlus, D., Yahi, N. (2010) -
Quantitative, Label-Free Detection of the Aggregation of α-Synuclein Using Microcantilever Arrays Operated in a Liquid Environment
Journal of Sensors; http://dx.doi.org/10.1155/2012/874086.
Jensen J, Farina M, Zuccheri G et al (2010) -
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
Neurochemistry International; Volume 58, Issue 7, June 2011, Pages 785–793 DOI: 10.1016/j.neuint.2011.03.004.
Verhaara, R., Jongenelena, CA,, Gerardb, M., Baekelandt, V., Van Dama, A., Wilhelmusa, MM., Drukarcha, B. (2010)
